- Lobbying
- Lobbying by Paratek Pharmaceuticals
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Oliver Meissner | CEO |
Brandon Kirby | n/a |
Ethan Mahler | n/a |
Meagan Daly | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Secret Service
Defense - Dept of (DOD)
White House Office
Air Force - Dept of
Type of Issue
Defense
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Secret Service
Defense - Dept of (DOD)
White House Office
Air Force - Dept of
Type of Issue
Defense
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Secret Service
Defense - Dept of (DOD)
White House Office
Air Force - Dept of
Type of Issue
Defense
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Secret Service
Defense - Dept of (DOD)
White House Office
Air Force - Dept of
Type of Issue
Defense
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Secret Service
Defense - Dept of (DOD)
White House Office
Air Force - Dept of
Type of Issue
Defense
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Secret Service
Defense - Dept of (DOD)
White House Office
Air Force - Dept of
Type of Issue
Defense
Registration
Issue(s) they said they’d lobby about: The ASPR SNS, DOD, and DHS stockpiles must be constantly updated to address bioweapons threats and antimicrobial resistance and contain an adequate amount of countermeasures and treatment courses for U.S. Citizens, including Federal Agents and U.S. Military Service members..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate